OTCMKTS:ANPCY ANGLE (ANPCY) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free ANPCY Stock Alerts C$1.89 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Today's RangeC$1.89▼C$1.8950-Day RangeC$1.80▼C$2.0452-Week RangeC$1.13▼C$4.00VolumeN/AAverage Volume1,105 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsShort InterestStock AnalysisChartFinancialsSEC FilingsShort Interest Get ANGLE alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About ANGLE Stock (OTCMKTS:ANPCY)ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.Read More ANPCY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ANPCY Stock News HeadlinesSeptember 4, 2023 | proactiveinvestors.comANGLE unveils groundbreaking cancer diagnostic toolSeptember 3, 2023 | msn.comWWE Hall Of Famer Kurt Angle Comments On Deaths Of Terry Funk And Bray WyattApril 27, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.September 2, 2023 | yahoo.comKurt Angle’s Documentary Wasn’t Originally Intended For PeacockSeptember 1, 2023 | msn.comKurt Angle Had Wanted To Wrestle John Cena In Last WWE MatchSeptember 1, 2023 | msn.comOne-on-one with Kurt Angle: His proudest and darkest moments in the spotlightSeptember 1, 2023 | yahoo.comKurt Angle To Have Shoulder Replacement SurgerySeptember 1, 2023 | yahoo.comNew WWE Kurt Angle Documentary Trailer Promises Details About The Superstar's CareerApril 27, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.September 1, 2023 | msn.comKurt Angle on Gable Steveson and what he needs to become a starSeptember 1, 2023 | yahoo.comEverything You Need to Know About WWE Hall of Famer Kurt AngleSeptember 1, 2023 | msn.comKurt Angle Peacock Documentary Director says Kurt Was Very Open About His LifeNovember 10, 2022 | foxnews.comAngle: Big TakeawaysNovember 8, 2022 | marketwatch.comMini Dental Contra-Angle Market Size, Industry Share 2023, Market Research with Growth, Manufacturers, Segments and 2028 Forecasts ResearchNovember 6, 2022 | msn.comKurt Angle On What Makes Jon Moxley SpecialNovember 4, 2022 | msn.comKurt Angle Calls Top WWE Star 'The Next Shawn Michaels'November 3, 2022 | msn.comKurt Angle Reflects On Wrestling Cody RhodesNovember 3, 2022 | marketwatch.comEndodontic Contra Angle Market 2022 : Report Offers Key Futuristic Top Trends And Competitive Landscape By 2028November 1, 2022 | msn.comKurt Angle Believes WWE 'Missed The Boat' With Top AEW StarOctober 31, 2022 | marketwatch.comAngle Plates Market 2022 Latest Research, Top Impacting Factors, Growth Strategies and Forecast to 2028October 29, 2022 | msn.comVince McMahon Yelled At Kurt Angle Over This MoveOctober 28, 2022 | marketwatch.comAngle Bars Market Outlook, In-depth Analysis, Industry Drivers, Key Trends, Projections, and Future opportunities for the period 2022 2028October 26, 2022 | msn.comOther Angle Pictures To Launch Sales On Crime Thriller ‘Double Down South’ Starring ‘Sons of Anarchy’ Actor Kim Coates — AFMOctober 26, 2022 | news.yahoo.comAngle: An Escape for New YorkOctober 25, 2022 | msn.comKurt Angle Names The Most Underrated Wrestler Of All-TimeOctober 25, 2022 | msn.comKurt Angle Explains Why MMA Fight With Ken Shamrock Never HappenedOctober 24, 2022 | msn.comTriple H blocked Kurt Angle's return to WWE back in 2014 due to real-life heatSee More Headlines Receive ANPCY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ANGLE and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolOTCMKTS:ANPCY CUSIPN/A CIK1620678 Webwww.angleplc.com Phone441483343434FaxN/AEmployees173Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Andrew David William Newland ACA (Age 63)Meng, Founder, CEO & Executive Director Comp: $326.51kMr. Ian Francis Griffiths ACA (Age 60)BA, CFO, Finance Director, Company Secretary & Executive Director Comp: $202.84kMr. Martin Cooke (Age 55)Director of Operations & Regulatory Affairs Dr. Karen Miller Ph.D.Chief Scientific OfficerMr. Andrew John Holder (Age 56)Head of Investor Relations Ms. Anne-Sophie Pailhes-JimenezHead of R&D and Senior DirectorMr. Brett SwansigerChief Commercial OfficerMr. Nick ClaxtonSenior Vice President of Commercial OperationsMore ExecutivesKey CompetitorsbioAffinity TechnologiesNASDAQ:BIAFWEpigenomicsOTCMKTS:EPGNYEternity HealthcareOTCMKTS:ETAHIntegral DiagnosticsOTCMKTS:ITGDFIntegrated DiagnosticsOTCMKTS:IDGXFView All Competitors ANPCY Stock Analysis - Frequently Asked Questions How have ANPCY shares performed in 2024? ANGLE's stock was trading at C$1.52 on January 1st, 2024. Since then, ANPCY stock has increased by 24.3% and is now trading at C$1.89. View the best growth stocks for 2024 here. How do I buy shares of ANGLE? Shares of ANPCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:ANPCY) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ANGLE plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
